Goldman Sachs
GRTS

Goldman Sachs’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Goldman Sachs’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,159,891
Closed -$717K – 6143
2024
Q2 		$717K Buy
1,159,891
+683,093
+143% +$577K ﹤0.01% 4623
2024
Q1 		$1.23M Buy
476,798
+339,644
+248% +$830K ﹤0.01% 4212
2023
Q4 		$280K Sell
137,154
-48,557
-26% -$88.6K ﹤0.01% 5037
2023
Q3 		$319K Buy
185,711
+55,488
+43% +$98.5K ﹤0.01% 4871
2023
Q2 		$254K Sell
130,223
-145,542
-53% -$341K ﹤0.01% 5092
2023
Q1 		$767K Buy
275,765
+150,933
+121% +$431K ﹤0.01% 4579
2022
Q4 		$431K Buy
124,832
+746
+0.6% +$2.13K ﹤0.01% 4952
2022
Q3 		$319K Sell
124,086
-31,929
-20% -$102K ﹤0.01% 5270
2022
Q2 		$378K Sell
156,015
-133,882
-46% -$352K ﹤0.01% 5276
2022
Q1 		$1.19M Sell
289,897
-151,864
-34% -$805K ﹤0.01% 4681
2021
Q4 		$5.68M Buy
441,761
+378,936
+603% +$4.2M ﹤0.01% 3289
2021
Q3 		$679K Buy
62,825
+29,160
+87% +$265K ﹤0.01% 5010
2021
Q2 		$307K Sell
33,665
-59,385
-64% -$549K ﹤0.01% 5509
2021
Q1 		$877K Buy
93,050
+55,415
+147% +$763K ﹤0.01% 4712
2020
Q4 		$148K Sell
37,635
-37,307
-50% -$113K ﹤0.01% 5187
2020
Q3 		$198K Buy
74,942
+36,635
+96% +$136K ﹤0.01% 4920
2020
Q2 		$254K Buy
38,307
+14,596
+62% +$98.3K ﹤0.01% 4700
2020
Q1 		$138K Sell
23,711
-4,411
-16% -$37K ﹤0.01% 4857
2019
Q4 		$252K Buy
28,122
+14,406
+105% +$120K ﹤0.01% 4818
2019
Q3 		$118K Buy
13,716
+2,392
+21% +$24.2K ﹤0.01% 4938
2019
Q2 		$126K Buy
+11,324
New +$130K ﹤0.01% 4889
2018
Q4 		– Sell
-295,711
Closed -$4.21M – 5768
2018
Q3 		$4.21M Buy
+295,711
New +$4.21M ﹤0.01% 3110

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Goldman Sachs's GRTS Position: Q3 2024 in Review

Goldman Sachs sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 1,159,891 shares — an estimated $717K sold.

Goldman Sachs first reported a position in GRTS in Q3 2018 and held it in 22 quarters. The position peaked at $5.68M in Q4 2021. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Goldman Sachs reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 1,159,891 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $717K.
  • Goldman Sachs first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 22 quarters.
  • Goldman Sachs's Gritstone bio, Inc. Common Stock position peaked at $5.68M in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.